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ani::-1.al, indicc_t:.nr: l:l·;s c}"J_runb -:"s ~-rc~:-'0 r-enc~---o_bls to ant~~_bodies. 
vree: 
the isologous hosts indefinitely, and about two weeks in the 
homologous host, although sometimes dying later. In homolo-
gous hosts previously immunized, the target cells usually 
died within two weeks. 
With isologous mice as hosts to the target cells, the 
combination of washed spleen cells from mice immunized to 
the target cells in "cell-impenetrable" chambers tended to 
kill the target cells within a week. In controls addition 
of isologous or homologous nonimmunized spleen cells had no 
effect during the flrst week, although later the target cells 
exposed to the homologous spleen cells sometimes died. 
Observations suggested that the "immunized" cells which 
were responsible for the death of target cells were lympho-
cytes, and when these lymphocytes contacted cells to which 
they had been immunized, both types of cella died. Such 
death was followed by the release of the diffusible sub-
stances which killed nearby cells of both types. 
These results were interpreted as implying that homo-
grafts in mice are usually destroyed by close association 
with immunized host cells that were probably lymphocytes 
rather than exposure to circulating noncellular antibodies. 
It was added that these results aPe compatible with the 
hypothesis that the antibodies to homografts are transported 
by lymphocytes. 
In 1957 Woodruff, (39) applied the diffusion chamber 
technique to split skin homografts and found they would 
survive when protected from contact with host cells, even 
if the host was immunized against the skin. 
4· 
Methods. 
Construction of Diffusion Chambers: 
In all cases, the chambers were constructed with 
Millipore Filter•Paper (MF), type HA, with a pore diameter 
of 0.45 V (26). The paper, made of cellulose, has been used 
by many workers for the in vivo culture of tissue. Accord-
ing to Weaver, Algire, and Prehn (37), paper of this por-
j. 
osity will permit the passage of metabolites into the chamber, 
but exclude cells. A recent paper b•r Algire and Moore (2) 
suggests that paper with pores of 0.45 p is not entirely 
cell-impenetrable; but even so, results definitely indicate 
that cells involved in homograft destruction are unable to 
enter the chamber in sufficient number to have any apparent 
effect. 
Four types of chambers have been used. ~~e Lucite-
ring chamber of Weaver, Algire, and Prehn (37) was tried 
but abandoned after one test. 
To cultivate tissue in vivo a chamber made with three-
~B} quarter inch Scotch Tape as designed by Duthie (14) has been 
used. This consists of a length of Scotch Tape with two 
one-quarter inch holes punched in it with a Gem';.:;.:·, paper-
--·-·----·- ·-- --------·-- ----· 
i<The Millipore Filter Cornorntion, Bedford, Hassachusettes. 
,;.::-Minnesota Mining & M:fg. Co., Saint Paul 6, Hinn. 
*';.:~McGill M. P. Co., Harengo, Ill. 
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punch. Two 13 mm. discs of MF paper are placed over the holes, 
and the ends of the Scotch Tape are attached to a piece of 
paper for ease in handling. The chamber, placed in a Petri 
dish, is autoclaved fifteen minutes at 120° c. vfuen used, 
tissue is placed on the ~1F paper, and the Scotch Tape is 
folded over so that the sticky sides approximate each other. 
The tape is pressed together with heated forceps to assure 
proper bonding. The tape is then trimmed, and the chamber 
is ready for implantation. Figure one shows the chamber 
as it appes.rs before receiving tissue. 
In two tests, a solution of antibody was injected into 
these chambers by inserting a hypodermic needle between the 
Scotch Tape. This was done every fifteen minutes for two 
hours. Between injections, the chamber was replaced intra-
peritoneally in the anesthetized rat. This method was 
clumsy, required a great deal of handling of the chamber 
with consequent danger of contamination, and did not permit 
sufficient contact time of enitbody with antigen. 
Since Amos and Wakefielf (5) found that many DBA/2 
lymphoma cells were lysed over a period of 4 to 24 hours by 
serum antibody, it was decided that antibody should rew~in 
in contact with target tissue at least a day to permit 
greater reaction. 
The inset on the following page is a sketch of the end 
of a chamber which was constructed out of rubber pressure 
tubing within which the antibody could be placed. The tubing 
is cut in ae>proximately one inch lengths. Gr~tves ar·e cut 
End Of Rubber Chamber 
~~----
Lip of ruh ' er chamber being retracted to 
receive a 1\llF sandwich 
with a scalpel on the inside of the tubing appro,eimately two 
millimeters from each end and one-half the dis.meter of the 
7· 
tubing. In this rJay a lip is made at each Elnd of the tubing. 
\fith scissors the l:i.p is cut through at three equidistant 
points at the end of the tube. Two pieces of MF paper punched 
out with a Gem paper-punch are placed together with a piece. 
of tissue in between, forming a sandwich. Wlth hemostats 
the lip of the chamber is grasped between the cuts. With the 
chamber held up and the hemostats allowed to hang down, the 
lip ls opened, and the f.1F sandvrich is dropped ln place. The 
Hemostats are then carefully removed, and the lip falls back 
in place, firmly holding the sandwich at the end of the tube. 
The same procedure is repeated at the other end of the tube. 
The solution to be tested may then be in,jected into the 
cavity of the tube directly through the r~ubber walls with 
a 1124 hypodermic needle. Thus the solution can only pass 
out through the sandwiches at the end, thereby bathing : "~ ~ 
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the tissue, and metabolites pass into the sandwiches when the 
tube in implanted. Control tissue in this chamber looked 
very healthy, but results of the 24 hour experiment were 
not conslusive. Weaver, Algire, and Prehn (38) studying 
the interaction of immunized spleen cells with target tissue 
left their chambers in place seven days. Therefore to make 
sure the antibody had sufficient time to react, it was 
decided to extend these present experiments for seven days. 
The rubber chamber is not perfectly sealed. The 
evidence obtained showed that infiltration of the sandwiches 
had not occurred after placement for 24 hours, but the risk 
of infiltration was too great to try using these chambers 
for a seven day study. Therefore a chamber was constructed 
out of 3/8 inch Lucite rod. The rod is drilled out, leaving 
a bore of 0.2 inch. Then both ends are re-bored to a depth 
of 0,1 inch with a 0.25 inch bore. On the resulting rim the 
above described sandwich is placed, and a Lucite friction 
ring with a bore of 1/8 inch is jammed into rlace. Before 
the sandwich is placed in the other end, the tube is filled 
with the fluid to be tested. Figures two and three show 
this chamber before and during loading. 
Sterilization. 
The Scotch Tape chambers are sterilized in the auto-
clave at 115° C. under 20 lbs. pressure for 15 minutes. 
The MF discs for the tube chambers are separately 
autocle.ved. The rubber tube is sterilized by boiling in 
water for fifteen minutes. The Lucite tubes are sterilized 
in ethylene oxide gas at 70 em. Hg for four hours, as re-
commended by Mr. E. Gianferrari (personal communication). 
Figure four shows his gaseous sterilization apparatus. 
Imnlantation of Chambers. 
All chambers are implanted intraperitoneally. Ventral 
subcutaneous implantations have been tested, but they result 
in gross inflammation. 
Before receiving the chamber, the rat is anesthetized 
with ethyl ether. The area of the incision is shaved and 
painted with iodine solution. By means of sterile instru-
ments, a midventral incision is made through the skin about 
two centimete!'S above the pubic symphysis and extended : 
approximately three centimeters craniaa. The ventral abdom-
inal muscles are then cut with a two centimeter incision. 
The chamber is nlaced intraperitoneally, lateral to the 
incision, and may be sutured with one stitch to the abdominal 
muscles. The incision through the muscles is then sutured 
with a 3/9 inch circle cutting edge needle and #50 surgical 
silk. The epithelium is closed with wound clips. 
Staining of Chambers. 
The method of staining the tissue is a variation of 
that desc~ibed by Weaver, Algire and Prehn (37). Having 
been placed between two MF discs, the tissue is sufficiently 
flat so that it does not have to be sectioned. The tissue 
is stained in the chamber. Weaver and co-workers, after 
clearing the tissue and MF paper, WeT'e able to study the 
tissue directly thi'ough the chamber. This method was tried, 
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but resolution was not sufficient to observe the cells 
clearly. Therefore, after being stained and cleared, the 
chambers are opened and mounted tissue side up. 
Weaver and co-warders ~ive the following technique for 
staining the chambers: the intact chamber is fixed in Helly 1 s 
formula for Zenker-formol for four hours. A cotton swab is 
used to remove cells from the external surface. This pro-
cedure is followed by standar·d treatment with Lugol• s sol-
ution and hypo to remove the fixative. The chambe~ is then 
rinsed in distilled tvater and stained Hith Harris alum hema-
toxylin for two to six minutes. At this point the remaining 
host cells are removed from the surface, and the chsmber 
placed in dilute ammonium hyd~oxide for approximately thirty 
seconds until it becomes blue. The chamber is then de-
hydrated with absolute alcohol and cleared Hith xylol. The 
previously onaque material becomes tr·ansparent. 
This method was followed except for one ·change: instead 
of using dilute ammonium hydroxide, alcohol Hith sufficient 
ammonium hydroxide to give it a nH of 8 was used after the 
chamber had been placed in acid alcohol. Where Weaver et al. 
used chambers made Hith Lucite rings, the cha~bers in this 
eXPeriment were made with Scotch Tane, and they only par-
tially cleared since the Scotch Tape had not been removed 
with xylol bef01'e the chambers wc:.··e deh~rdrated. 
Tissue VTSs imnlanted in Scotch Tape chambers in five 
animals. Six minutes in hematoxylin was found to be in-
sufficient to stain the nuclei. Therefore a test Has run 
varying the time tissue Has left in hematoxylin. 
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Four Scotch Tape chambers received approximately one-
half a cubic millimete~ of subcutaneous .connective tissue 
and vrere immediately placer:'. in Helly 1 s fluid for twenty-feu 
four hours, and then washed in wnter for twenty-four• hours. 
They we:r>e t!Jreated for fifteen minutes in Lugol 1 s solution 
and fifteen minutes in hypo. After varying treatment in 
hematoxylin, they w;:c'e placed in acid alcohol for three 
minutes and basic alcohol for two minutes. Table 1 summa•-· 
rizes the results. 
Chamber 
N1ll!lber 
1 
2 
Table 1 
Effect of Time in Harris Alum Hematoxylin 
on Density of Nuclear Stain __ ... ___ 
Time in Results 
Hematoxvlin 
-
5 minutes Nuclei very lightly 
10 minutes Nuclei stained well 
-------
stained 
3 20 minutes liuclei lightly stained 
L~ 30 minutes Nuclei stained well 
See text for explanation. 
'l'hese results were not consistent and sho1-red that some 
othe:c· factor was interfering with the staining in the twenty 
minute test. However, it is evident that at least ten minutes 
are necessary <"nd thiPty minutes are not too much. Further 
tests have shown that twenty minutes is a s:dfficient time. 
Unfortunately, slides prepared using this technique 
alovrly lost their color. This loss of colo:• was attributed 
to an acid residue in the tissue from acid alcohol. The 
chambe:es are now ':>laced for four minutes in acid alcohol 
and for six minutes in basic alcohol. 
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A further problem has been encountered. After re;roving 
a chamber in which tissue had been placed fr•om the peri-
toneal cavity, it was often found to be impossible to see 
much of the tissue afteP staining due to an amorphous sub-
stance surrounding it. This might be a proteinaceous sub-
stance from the body fluids that had been ~recipitated in 
the chamber upon fixation. Consequently, after removal from 
the body cavity, saline is quickly drawn through the walls 
of the chamber with a medicine dropper before fixation. 
This flushes body fluids out of the chamber, and seems to 
eliminate the problem. Experience with chambers with a 
la2ge1' cavity shows that when they are removed from the 
peritoneal cavity, and the nuid inside them p;taced in 95% 
ethanol or in Zenker-formol, the fluid immediately pre-
cipitates, which is typical of the behavior of protein sol-
utions under these conditions. It is unknown why other 
Harkers using this technique have not mentioned the problem. 
Animals Used. 
In order to study homograft reaction, it is by definit&on 
necessary to have unrelated strains of animals. Therefore 
two inbred strains of albino rats ('lattus norweg~~) were 
obtained;': Charles River Wistar and Charles River Sprague-
Dalvley, which will hereafter be refel'red to as W and $. 
Since very young rats may not exhibit antibody production 
(20), they were ordered at approximately three months of 
age, and at the time of the last experiment reported in 
---------------- -- ------------
*Charles River Breeding Laboratiories Inc., Cambridge, Mass. 
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this paper were about one year old. 
Tissue Used in Transplantation Experiments. 
Due to the great amount of work that has been done 
with skin grafting, it was first decided to use homologous 
skin in these experiments. However it was discovered that 
using epithelium without first separating the epithelial 
cells from the keratin by trypsin (38) was not practical. 
It was decided that another tissue that required less treat-
ment would be more desirable. Consequently a spread of 
ventral-abdominal muscle fascia, subcutaneous connective 
tissue and peritoneum was made and stained with hematoxylin 
and eosin. It was decided that subcutaneous connective 
tissue was the most appropriate, although with older rats 
adipose tissue is often attached to it (see Figure 8). All 
of the tissue stained well, but muscle fibers were taken up 
with the fascia, and use of peritoneum requires relatively 
' tim~consuming surgery, subjecting the animal to unnecessary 
trauma. 
Stimulating Antibody Production, 
Although lymph-nodes have been shown as a source of 
antibody, Coons, Leduc, and Connolly (12) showed that anti-
body to human g~~a-globulin or ovalbumin is present in 
groups of plasma cells in the red pulp and occasionally in 
the lymphoid follicles of the spleen, as well as the lymph 
nodes. Algire, Weave~, and Prehn (3 and 38) demonstrated 
that grafts were destroyed by contact with spleen cells. 
Therefore the spleen was used as a source of antibodies. 
In order to immunize the spleen, approximately one 
cubic millimeter of homologous rat subcutaneous connective 
tissue was removed, mixed with ap~roximately 0.25 cc aqueous 
salt solution (NaCl 0.9%, CaC12 0.026;/,, and KCl 0.03~0, and 
broken up in a Potter-Elvehjam tissue homogenizer, so that 
' 
it ,,-ould pass through a #20 gauge hypodermic needle. The 
antigenic tissue was injected intraperitoneally. 
It is uncertain which is the best time to remove the 
spleen in order to get the maxim~ number of cells carrying 
antibodies. Skin g1'afts in rats are rejected in eight days 
in the first set reaction ( 36), and in rabbits in four days 
in the second set reaction (23). It is assumed that if anti-
body carrying cells are of spleenic origin, there would be 
antibody containing cells in the spleen from 6-7 days after 
the first injection of antibody, and in 2-3 days if two 
injections Here given at a widely spaced interval. 
Leduc, Coons and Connolly (22) showed that after one 
injection of antigen, serum antibodies were first seen in 
spleen cells in four days and were maximum at eight days. 
When two injections were given five weeks apart, there were 
maximum amounts of antibodies four days after the second 
injection. This was a much stronger reaction than the first 
set reaction. 
Weaver et al. (38) injected antigenic tissue 8-:13 days 
before removing the spleen with good results. Billingham 
et al. (7) found that in guinea pigs sensitized by injection 
of homologous spleen, iw~nity comes into force between two 
to three days after eXposure to antigen. 
For this paper, except -where noted, two injections of 
antigen have been given, and the spleen has been removed 
from one to four days after the last injection. 
Treatment of Spleen Cells fnu Placing >nth Target Tissue. 
In these tests, homologous spleen sensitized against 
subcutaneous connective tissue cells, and nonsensitized 
homologous spleen have been used as controls. The treat-
ment of both is the same. 
The donor is killed with ether, and the spleen is 
innnediately removed aseptically and placed in a sterile Petri 
dish. It is ID8Cerated with scissors. If it is desired to 
place spleen tissue with target tissue, a small piece is 
teased away and b'ansferred to a chamber. 
In testing whether it is possible to separate antibod~ 
from spleen cells, the macerated tissue is placed in a steri-
lized tissue homogenizer with approximately one volume of 
chilled saline solution, This solution is ke--,t at a minimum 
volume in order not to unduly dilute the homogenate. The 
tissue is well homogenized for three to four minutes and 
poured into a four inch centrifuge tube. The homogenate 
is then placed in a Genco table centrifuge dilled with dry-
ice, and spun down for ten minutes. The supernatant is 
decanted into a sterile test tube and kept at 30 c. until 
use. Microscopic examination of the supernatant has not 
revealed any whole cells. 
As previously mentioned, this fluid i~ brought in con-
tact with target cells either by injecting it into Scotch 
Tape chamber·s, or by placing it in a tube so that it may 
diffuse out through the target tissue. 
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RESULTS 
P:'eliminary work involved as study of construction of 
chambers, and attempts to grow and stain tissue in them. 
The double Lucite ring chamber of \>leave:' et al. ( 37) 
was tested. It was found that sterilizing the chamber in 
isopropyl alcohol dissolved the glue used to cement the MF 
paper to the Lucite. The chamber was implanted intraperi-
toneally in a rat, and upon removal five days lateP was 
found to be mildly encapsulated with adipose tissue. There 
was no sign of inflammation, and the chamber was infiltrated. 
This chamber has been rejected in favor of Scotch Tape 
chamber~ as designed by Duthie (14), which are very simple 
to make, and can be sterilized in the autoclave. 
Two Scotch Tape chamber>s were made and were sterilized, 
and epithelium approximately one-half a cubic millimeter was 
placed in each. They were then livfttly pressed together to 
seal them and placed in saline solution to test the seal. 
Then they were placed in a SD rat, one subcutaneously and 
the other intraperitoneally. Two days later the chambePs 
were removed. It was found that they had both become unsealed 
and were so infil tr·ated that no attempt was made to stain 
them. The intraperitoneal imolantation was not inflamed, 
but the subcutaneous implantation caused considerable hem-
or~'hage. 
Since the chambers did not remain S'oaled, it was 
apparent that if Scotch Tape was to be used, it would have 
to be more securely bonded. Therefore two 11 dummy 11 chambers 
1?. 
were made and sealed by running heated forceps over the 
Scotch Tape surface. They were then soaked 48 hours in 
saline, and did not become unsealed. 
Two Scotch Tape chambers received epithelium and vrere 
heat sealed. One was placed subcutaneously in a rat, and 
the other intraperitoneally. Three days later they were re-
moved. Since the subcutaneous site hemorrhaged, it was 
abandoned. The intraperitoneal im~lant had a fatty encap-
sulation. These chambers were stained according to the 
method of Weaver et al. (37) and opened. The nuclei wer·e 
too lightly stained to see details, but the chambers may 
have been infiltrated. 
To test for infiltration of these chambe''s, two were 
const:·ucted and placed int:>:>aperi toneally in two separate 
rats. They vrere removed four days later and stained in 
hematoxylin. The inside surfaces Here viewed dic.'ectly 
through the chambers. '['hey were not infiltrated, but were 
filled with precipitated ~rotein. 
The chamber described by Duthie (14) was constructed 
from Sellotape, of British manufacture. Although this may 
be the same as Scotch Tape, it was conceivable that Scotch 
Tape might be sufficiently different as to be toxic to re-
gene:>:>ating cells. Therefore, before trying to regenerate 
cells in chambers made of Scotch Tane, it was decided to 
make a toxicity test. This was done by implanting a chamber 
that was perfectly sealed except for one small area. It was 
felt that if cells penet~ating into the Scotch Tape chamber 
survived, the tare must be sufficiently inert to be usable. 
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After three days connective tj_ssue was found to have entered 
the chamber through the imperfection in the Scotch Tape. 
Experiments were pec•formed to demonstrate the pattern 
of regeneration of autografts and homo;;rafts of subcutaneous 
connective tissue in MF cha1nbers eve•: a pe:·iod of several 
days. The results are summarized in Table 2. Figure 6 
shows the growth of healthy connective tissue cells in one 
of these chambers. 
Table 2 
Connective Tissue Regeneration 
in MF Chambers 
Days Tissue 
:oegenerated 
2 
4 
6 
8 
'lesults and 
Observations 
-----···----~,-J 
Cells appear healthy. Little sign of 
regeneration, althourJ" a few cells 
were seen to be growing a1-ray from the 
area of the graft. 
Cells streaming away from the site of 
graft; regenerating well. 
Results unsu~·e due to chamber not 
properly clearing. However, cells 
apDear to regenerate and to be healthy 
I Autograft not well regenerated, but ' 
,.._ _______ _L_ ~~:'~~~- :!k~~,~-~~~-~-~~~~~-~~ ~-
See text for explanation. 
In all cases, except for day eight, the regeneration 
of autografts and homogra.fts are similar, which agrees 
with the results of Weaver, Algire and Preh~ (38). 
Experiments l-Tere run to test the effect of placing 
non-immunized homologous spleen cells in contact with sub-
cutaneous connective tissue. lieavsr et ~1 (38) repor·tsd 
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that the tissue will not be harmed by non~bTh~unized spleen 
cells, and this t-1as found to be true. 
Consequently, tests were performed placing immunized 
spleen cells, as well as the supernatant from homogenized 
spleen cells, t-rith target tissue. 
Subcutaneous connective tissue from two W rats was in-
jected intraperitoneally into two SD rats. Five days after 
receiving the antigenic tissue, the spleen from one of the 
SD rat·. was removed. Three chambers containing Wl rat 
connective tissue plus a small piece of SDl spleen tissue 
were placed in Wl. The rest of the spleen was homogenized, 
spun down, and the supernatant stored in the icebox over-
night. A non-immunized spleen f!'Om the SD strain was also 
homogenized, S'lUn down, and its supernatant similarly stored, 
Sixteen hours after implantation the tl.ro chambers 
containing the spleen and subcutaneous connective tissue 
were removed and fixed. One of the chambe~s with connective 
tissue was left intact as a control. One of the connective 
tissue chambers ''ecei-ved a total of 1.,5 cc. of the immun-
ized homolgsous spleen supernatant, injecteo into the chamber 
in small doses every fifteen minutes over a period of one and 
three-quar-ters hour. The other chamber received 1.25 cc. of 
su·,·ernatant fr-om the homologous non-immunized spleen under 
the same conditions. After each injection, these chambeT'S 
Here reulaced intraperitoneally in the anesthetized rat. 
Fifteen minutes after the last injection of supernatant, 
all the chambers were fixed. 
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The connective tissue grown alone was found to be 
healthy by the c:"iterion of densely-staining well-formed 
nuclei without pycnotic bodies. The connective tissue which 
had pieces of immunized spleen was slightly necrotic where 
contact with the immunized spleen occured, ·' as described 
by Algire (1). In some areas, no connective tissue cells 
were·visible nea~ the spleen cells, as shown in Figure 7, 
suggesting that they had been utterly destroyed. The tissue 
shown in this photograph was g~own for seven days. The 
connective tissue which had received the control supernatant 
appeared healthy. The tissue 'Which had received the super-
natant from the immunized spleen showed a slight loss of 
basophilia which Dr. D. I. Patt (personal communication) 
said is indicative of a moribund condition of cells. 
The fact that there was some destruction of the target 
tissue by the snleen cells suggests that the snleen cells 
W3re immunized against them. The slight loss of nbasophilia 
of the tissue receiving the supernatant from the immunized 
spleen is suggestive, but clearer demonstration of cellular 
death is required. 
A booster does of antigen from W2 wa~ given to SD2 
(the other homologous rat-pair of the series) ten days 
after the first does, and the spleen was removed from the 
SD rat the next day. An isologous W rat spleen was used 
for the control. Exactly the same procedure was follvwed , 
excent that the supernatants were injected oveco a period 
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of two hours and ten minutes. The results were the same 
as the first test: the immunized spleen indicated that it had 
antibodies since necrosis of the target tissue occuned in the 
presence of the whole spleen cells. The immunized super-
natant was associated With slight loss of basophilia in the 
target tissue. 
Due to these vague results tests were performed i~hich 
spleen supernatants were kept in contact with the target 
tissue for longer periods of time by using tube chambers. 
Two antigenic doses were given to a W rat from a SD rat 
eight days apart. Four days after the last dose the spleen 
was removed from the W nat, as well as the homologous spleen 
from a non-immunized W rat to serve as a control. They were 
each homogenized with equal volumes of saline and spun down 
in a chilled centrifuge. It was observed that the super-
natant fr·om the immunized spleen was much more viscous than 
that from the non-immunized. The only significance to this 
may be that there was a difference in the vol~e of saline 
in the two supernatants. The supernatants were placed in 
two ra.bber tube chambers along with the ta;cget tissue and 
implanted in the antigen donor SD rat within an hour after 
being whirled down. The supernatant was allowed to warm to 
room temperature befO!'e implantation. 
Twenty-two hours later the SD rat was killed with 
ether and the target tissue was removed immediately and fixed. 
Afte:- being stained, the tissue receiv:~ing the control spleen 
supernatant looked viable. One of the chambers with tar-r:et 
tissue in contact uith the immunized spleen looked viable, 
while the other was com~letely devoid of living cells. 
Figures 8 and 9, taken aftel' a later experiment, show 
such necrotic tissue. Although it is possible that this 
was caused by the antibody, this result must be !'ejected 
as an experimental error, since the tissue in the other 
end of the chamber was not affected in this way. 
Two antigenic doses from a SD rat Here given to a 
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W rat six days a:pa<·t. The W rat s-pleen vas removed four 
days later along with the spleen from a non-immunized W 
rat as control. The supernatants were treated as above 
and placed with ta:c•get tissue in rubber tube chambers. 
During implantation the host SD rat received 0.15 cc. 
adrenalin in peanut oil intramuscularly due to resp~ratory 
failure. The res;~ir£tion and heart response we:>:>e good. 
The tissue was removed and fixed 20 hou:>:>s later. The control 
tissue was viable, whe~eas the tissue from the immunized 
spleen did show signs of dissolution. Ther•e were minute 
black granules in some areas which were too small to be 
cocci, and may be cell fragments. 
Antigen was donated by a SD rat to two W rats. Four 
days later the immunized spleen was removed from one of the 
W rats and homogenized. The >Thole homogenate was "?laced 
in a rubber tube chamber, and the rest of the homogenate 
was centrifuged and the supernatant placed in another chamber. 
The chambers were placed in a SD rat isologous to the target 
tissue. On removing and staining the tissue a day later, 
it was seen to be healthy; the•'e was no apparent rejection 
by antibody. No control was run. 
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Five days after the antigenic dose the spleen was 
removed from the other W rat and the above experiment re-
peated. On staining the tissue from both chamber·s a df:Y 
later, mirrute black granules were seen throughout large 
areas, although there were also healthy looking cells. 
This may have been a sign of antibody activity, but the 
results are inconclusive. No control was run. 
At the time of removing the spleen from the above 
animal, a small amount of it was frozen to -70° c. and 
thawed three times to ca.use cell breakage. Part of the 
thawed spleen was placc;d in a Scotch Tape chamber and im-
planted in another SD rat, and part placed in a chamber -vTith 
tar•get tissue, and placed in the same SD rat. Upon reMov-
ing the chambers two days later and staining them, it was 
found that the chamber which received the spleen alone was 
devoid of cells, showing that the feeezing had destroyed 
the cells. In the chamber with the target tissue and 
frozen spleen, the taroget tissue was well regenerated. 
This would suggest that killed spleen does not release 
active antibody, but the •reakness in this experiment is 
that the freezing mir~t have destroyed the antibody. 
Antigen from a SD rst was given to 3 W rats. Seven 
days later the spleen was removed. io/hole spleen was 1Jlaced 
in three Scotch Tape chambers along with target tissue. 
Then the spleen supernatant was ph;_ced in two Lucite chambers 
with ta<~get tissue. When removed from the chambers seven 
days later, the tissue from the Lucite chambers was dead 
~. 
(Figures 8 and 9) and the tissue placed with the spleen 
cells was approximately 80% dead (Figure ?). 
When the homogenate was removed from the Lucite chamber, 
it was seen to have separated into a precipitated fraction 
and a clear fraction. The precipitated fraction was seen 
under the phase-contrast microscope to be composed of an 
amorphous substance throughout which was scattered crystals 
approximately 2 x 10-3 mm. long, and of a feathery appear-
ance. Their composition was not analyzed, but it would be 
interesting to do so. 
The Lucite tubes used in the above experiment were 
sterilized and filled with a homogenate from a non-immunized 
SD rat spleen, along with subcutaneous connective tissue from 
another SD rat. The chambers were placed in the SD donsting 
the tissue, making it an autologous implant. Seven days 
later the tubes were removed and the tissue stained. It was 
dead. Again the homogenate in the chambers had precipitated. 
Further tests with the Lucite chambers has shown that 
the area of diffusion into the MF sandwich is apparently 
insufficient to maintane the cells. New chambers are being 
designed, which will, it is hoped, circumvent this problem. 
DISCUSSION 
These experiments have not clearly demonstrated that 
the supernatant from an immunized spleen will destroy -
homologous subcutaneous connective tissue. However, the 
loss of basophilla from the target tissue in contact with 
supernatant fon two hours, and the suspected necrosis of 
tissue in contact with the supernatant for one day suggest 
that such rejection is taking ~lace. 
There are several variables to be considered in these 
results. Injection of antigen definitely immunizes the 
spleen, but it is not certain what is the best time to re-
move the spleen to obtain the gr>eatest :m.umber of cell-bound 
antibodies. The time factor is fairly critical for the 
supernatant, inasmuch as dead cells do not produce antibody 
(18). The experiments suggest that removing the spleen 
seven days after the first antigenic injection will give 
go<n. results. Unfortimately, it is only after obtaining 
tissue rejection with spleen supernatant that it will be 
possible to rtk~ quantitative tests on the best tL~e to remove 
the s-pleen. 
The proper time of contact between connective tissue 
cella and antibody has not been established by micPoscopic 
examination of the tissue as the criterion of cell death. 
A vast difference between the control tissue and antibody-
reacted tissue is necessary as proof. Two hour contact 
does not give this proof. Possibly a measure of cellular 
resp~ration, as suggested by Dr. I. A. Macchi (personal 
communication) or test of viability with trypan blue (19) 
would sho~r that two hour contact with antibody has inhibited 
the tissue function. 
Although Amos and Wakefield (5) found that serum anti-
bodies caused a significant lysis of tumor cells in chambers 
in four hours, this criterion can not be used with other 
tissue, since they also report that tumor tissue is much 
more sensitive to antibodies than other tissue. 
It is possible that antibodies may not be able to pass 
through !'JF paper with a pore diameter of 0.45 Jl, but Weaver, 
Algire and Prehn (38) found that equine g~~-globulin 
passed through chambers with a pore size of 0,30 }l without 
detedtable change in concentration. However, Amos and Wake-
field \4) found that antibody penet::.oation into cell impene-
trable chambe~s was slow. It might be advisable to use 
J.I!F paper of much larger pore size on the inside of the tube 
to overcome a diffusion problem. 
The titer of antibody may not be sufficiently high 
to permit :eeaction. Amos and Wakefield (4) found that the 
concentration of antibody was critical to obtain lysis of 
tumor cells. It may be possible to obtain a more concen-
trated solution of antibody by using both immunized spleen 
and lymph node supernatant. 
The changes that occurred in the spleen supernatant 
remaining in the Lucite chamber seven days may oe due to 
bacterial contamination. Hereafter it is planned to Dass 
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the supernatant through a bacteriological filter before plac-
ing it in the chamber. This would not only remove any 
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bacteria, but also any spleen cells which might be in the 
supernatant. Also, a carefully buffered saline will be used 
to hold down any change in pH. 
It is possible that enzymatic digestion of the cell-
bound antibodies takes place ••hen they are removed from the 
cell. Methods of inhibiting the enzymatic activity Hithout 
destroying the antibody will be investigoted. 
It is also possible that in homogenizing the antibody-
containing spleen cells, the antibody may react with the 
nuclear fragments of the broken spleen cells. The logic 
behind this will be elucidated in the discussion which 
follows. 
This discussion is an attempt to correlate various 
observations made in the literature about the differences 
in antibody reoction with antigens from different sources. 
Antibodies to foreign chemicals of a bacterial nature 
(20 and 34) and to cytoplasmic particles (29) a~e found in 
the serum of mammals challenged by injections of such foreign 
substances. This is also true of heterograft antibodies (1). 
However, the antibodies to homo grafts ac'e carried by cells, 
Antibodies to tumors are also demonstrated in the serum 
(4, 5, and 16), even though the tumors may be homografts. 
It is important to notice that the only clear case of cell-
bound antibodies occurs in the homograft situation. 
Antigens are stated to be always for·eign material, and 
never healthy cells of the host (34, page ~9L~). The prime 
requirement for antibody formation is that a large foreign 
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molecule, usually a protein, be introduced into the animal 
( 34, page 495) • 
Antigens responsible for skin transplantation immunity, 
or~iginally thought to be deoxyribonucleoproteins (8), are 
no•r thought to be similar to blood g'coup mucoids ( 7), al-
though there is some doubt about this (28). Oth and Caster-
mans (28) mention the hypothesis of G. D. Snell which states 
that antigens concerned with evoking a homograft reaction 
and humoral reaction are mucoid substances whose subsidiary 
attachments determine the cellular or humoral type of re-
sponse. Due to difficult Droblems of nurifying the antigens, 
nothing absolute can be said about them except that they 
may in some way be connected with the genome of the cell. 
Prehn and Main (31) stated that grafts tend to be 
successful if the recipient contains at least all the histo-
compatability genes present in the donor. They showed that 
heterozygous (BALB/c x DBA/2)F1 mouse skin grafts survive 
longer upon tr·ansplantation to strain DBA/2 recipients than 
do homozygous strain BALB/c grafts, demonstrating the genetic 
nature of the reaction. 
If it is true that something associated with genes 
re;·r·esen~ the antigen in the homograft rejection it can be 
hypothesized that the antibodies to homologous tissue can 
not be released into the general circulation, since they 
would immediately react autologously. Therefore they are 
carr-ied by cells which are perhaps dr-awn to the site of the 
graft by its inflammatory reaction and release of histamine 
like substances (34, page 508). 
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In light of this, it follows that heterograft rejection 
is humoral, since the animals are of different species with 
consequent diffe~ences in genome. 
There a::'e other substances in a cell beside chemicals 
within the nucleus which may act as antigens. Panijel and 
Barbu (29) have shown ribosomes to be antigenic, and there 
are undoubtedly many more. 
Stetson and Demopoulos (35) showed indications of a 
humoral rejection of homografts. Therei'ore there is reason 
to believe that homograft rejection is both cellular and 
humoral, with the cellular rejection being most important (35). 
Possible proof of this comes from the work with tumors 
which are rejected humorally. Amos and Wakefield state (4) 
that some cells ao:-·e considerably more sensitive to the action 
of serum antibodies than other's, The relative concentration 
of antibody to cells is critical and the ph~sical state of 
the cells can determine whether antibody can ~each the ma-
jority of the population or not. 
Gorer and Amos (16) presented evidence that circulating 
a.ntibodies play a simpler and more direct role in leukdltic 
homografts than other types of tissue. They performed some 
experiments that are worthy of careful analysis. 
Antibodies were produced against C57BL mouse leukosis 
E. L. 4 following intensive immunization of strains A, BALB/c, 
and C3H. Note that these are homologous hosts. Sera with 
antibodies when injected into mice of the three resistant 
strains gave nassive immunity to E. L. 4. A considerable 
degree of immunity to E. L. 4 was given to C57BL mice also. 
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These results appear to contradict the theory that anti-
bodies to homografts a~e carried by cells to urevent them 
from c•eacting with the genome of the host, However these 
workers did one other experiment which is e•ceedingly sig-
nificant. C57BL liver and spleen was injected into BALB/c 
mice. Previous work has shown that this homologous tissue 
will be destroyed by host cells (38), but sel'um antibodies 
Wel'e also produced because the immune Sel'um, when in;jected 
into another BALB/c gave passive immunity to E. L. 4· Yet 
the same serum did not immunize C57BL against this tumor. 
The mechanism of tumor rejection can be outlined as 
follows: of the multiple antigens of the tumor cell, some 
associated with the genes of the tumor were sufficiently 
different from the ho~~logous host genome that they were 
released into the host's serum. These antibodies were able 
to give passive immunity to the homologous host, as well 
as partial immunity to C57BL, the strain from which the 
tumor originated, Some of the tumor antigens were sufficiently 
unlike the C57BL normal cells that they only reacted with the 
tumor cells, and not with the normal cells. 
Serum antibodies produced in BP~B/c against C57BL normal 
cells were able to c>eact with the tumor, since its genome 
is somewhat similaY' to the C57BL. But it did not confer 
any immunity to C57BL, since according tb the hypothesis, 
these antibodies could react with any C57BL body cell, and 
had little chance of reaching the tumor site. 
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Berrian and Brent (6) tried to limit the survival time 
of skin homografts through the agency of cell-free homogenates 
of immune lymph nodes and spleen cells. The doses had no 
di,;,cernible effect on the immunological response of the 
homologous host. They supposed that the antibodies were never 
given the chance of reaching the graft site. 
Castellanos, Ketchel and Sturgis (11) immunized rat 
lymph nodes with a heterologous mouse tumor. The immunized 
nodes were removed from the rat, placed in diffusion chambers, 
and then implanted into mice sensitive to the tumor. These 
mice were later given injections of the same tumor, but 
there was only the slightest evidence that the nodes held 
• down the tumor. 
\ 
This agrees with the h1Pothesis that the rat antibodies 
\iere largely specific for the mouse genome, and may have never 
reached the tumor site in quantity. 
In summary, evidence from the literature suggests that 
antibodies against tissue are largely specific for the 
tissue genome. In the case of heterog:c'afts khere the gen-
ome is quite diffe"ent from that of the host, the antibodies 
appear in the general circulatl. on, but in homog1•aft rejection, 
the antibodies are carried by cells when they are similar to 
the host's genome, but may also appear• in the general circu-
lation \~en they are specific for chemicals foreign to the 
host. 
Experiments are being conducted to partially test this 
hypothesis. It has been found by Dietrich et al. (Cancer 
'"esearch 18:1272. 1958.) that the level of diphosphopyridine 
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nucleotide production is very low in tumor·s, as well as in 
normal lung tissue, although it is higher in other body 
tissue. Therefore there is a sliGht possibility that lung 
tissue may show the same sensitivit:;r to serum antibodies as 
tumor tissue. 
A series of tests have been performed which demonstrate 
that cells from lung alveole.e remain viable and ··egenerate 
well for at least two weeks in NF Scotch Taue chambees, At 
present lung tissue in ~W chambers is being grown in homol-
ogous hosts that are immunized to the lung tissue. Subcut-
aneous connective tissue from the animal that donated the 
lung is also being gT·own in MF chambel>s in the same immune 
homologous host. The subcutaneous connective tissue should 
not be rejected by the immunity of the host (37). If it is 
not rejected, while the lung tissue is .:"ejected, He will have 
an indication that serum antibodies are associated with 
homog:,"aft destruction, and that tissues vaPy in their sen-
sitivity to seru~ antibodies. 
Further experiments to test this hypothesis are being 
studied and shall be performed this summer. 
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SUMMARY 
A study of growing rat subcutaneous connective tissue 
and spleen cells in diffusion chambers in vivo and of 
staining procedures has been presented, 
The cell-free supernatant of an immunized spleen has 
been placed with antigenic subcutaneous connective tissue 
for periods of two hours, one day, and seven days. The 
immunized supernatant caused slight loss of basophilia in 
the target cells when in contact with them for two hours. 
When in contact with them for one day, black granules were 
seen in the target tissue, although there were apparently 
healthy cells too. The seven day tests are negative, since 
both the control and immunized supernatant killed the target 
tissue. It is felt that tests indicate that the umnune 
homogenate is demonstrating antibody activity, but many more 
tests will have to be run before this is proven. 
Variables in this experiment are discussed, and further 
tests sug~ested. A hypothesis is presented to explain why 
homograft tissue antibodies a1•e cell-bound, while antibodies 
to other antigens appear in the serum. 
